WebApr 11, 2024 · Description of a single centre cohort of patients with systemic sclerosis from the University Hospital of Buenos Aires and factors associated with lung function deterioration. ... telangiectasias confirmed by a physician at any time during disease course and Raynaud's phenomenon by colour changes usually caused by cold exposure. 21 ... WebMay 14, 2024 · The purpose of the trial is to achieve a vasodilatory effect in subjects with Raynaud's phenomenon by stimulation of the AT2R with C21. Study Design Go to Resource links provided by the National Library of Medicine MedlinePlus Genetics related topics: Raynaud phenomenon Systemic scleroderma MedlinePlus related topics: Scleroderma
Efficacy of nifedipine in Raynaud
WebOct 5, 2024 · CREST (calcinosis, Raynaud phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia) syndrome is a member of the heterogeneous group of sclerodermas, and its name is an acronym for the cardinal clinical features of the syndrome.[1, 2] In 1910, Thibierge and Weissenbach described the first case report of … WebSystemic Sclerosis is a multisystemic disease characterized by sclerosis of the skin and visceral organs, vasculopathy (Raynaud's phenomenon) and autoantibodies. The criteria for the classification of the disease requires either proximal scleroderma (major criteria) or the presence of 2 of the 3 min … Systemic sclerosis Singapore Med J. bpx hmemcpy
Management of Raynaud
WebMar 8, 2024 · Raynaud phenomenon (RP) is an exaggerated vascular response (ie, vasospasm) to cold temperature or to emotional stress, which is manifested clinically by discomfort and sharply demarcated color changes of the skin of the digits (fingers, toes). The treatment of severe or resistant RP including measures to limit or reverse acute … WebRaynaud’s phenomenon. Raynaud’s phenomenon causes white, blue and red color changes to your child’s fingers and/or toes when they're exposed to cold or stress. This condition is present early in the disease’s course and may be a sign of systemic sclerosis. Other symptoms of Raynaud’s phenomenon include: Fatigue. Joint pain. WebRaynaud’s phenomenon (RP) is present in more than 95% of patients with scleroderma (systemic sclero-sis [SSc]) and typically precedes the onset of systemic disease by several years. The effect of RP on quality of life and functioning in patients with SSc is highly variable and depends on multiple factors, including the fre- bpx herts